|
1
|
He Y, Rajantie I, Pajusola K, Jeltsch M,
Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T and
Alitalo K: Vascular endothelial cell growth factor receptor
3-mediated activation of lymphatic endothelium is crucial for tumor
cell entry and spread via lymphatic vessels. Cancer Res.
65:4739–4746. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hosseini H and Nejabat M: A potential
therapeutic strategy for inhibition of corneal neovascularization
with new anti-VEGF agents. Med Hypotheses. 68:799–801. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cursiefen C, Chen L, Dana MR and Streilein
JW: Corneal lymphangiogenesis: Evidence, mechanisms and
implications for corneal transplant immunology. Cornea. 22:273–281.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cursiefen C, Maruyama K, Jackson DG,
Streilein JW and Kruse FE: Time course of angiogenesis and
lymphangiogenesis after brief corneal inflammation. Cornea.
25:443–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bachmann BO, Bock F, Wiegand SJ, Maruyama
K, Dana MR, Kruse FE, Luetjen-Drecoll E and Cursiefen C: Promotion
of graft survival by vascular endothelial growth factor a
neutralization after high-risk corneal transplantation. Arch
Ophthalmol. 126:71–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cursiefen C, Cao J, Chen L, Liu Y,
Maruyama K, Jackson D, Kruse FE, Wiegand SJ, Dana MR and Streilein
JW: Inhibition of hemangiogenesis and lymphangiogenesis after
normal-risk corneal transplantation by neutralizing VEGF promotes
graft survival. Invest Ophthalmol Vis Sci. 45:2666–2673. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lymboussaki A, Achen MG, Stacker SA and
Alitalo K: Growth factors regulating lymphatic vessels. Curr Top
Microbiol Immunol. 251:75–82. 2000.PubMed/NCBI
|
|
8
|
Oh SJ, Jeltsch MM, Birkenhäger R, McCarthy
JE, Weich HA, Christ B, Alitalo K and Wilting J: VEGF and VEGF-C:
Specific induction of angiogenesis and lymphangiogenesis in the
differentiated avian chorioallantoic membrane. Dev Biol.
188:96–109. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Breiteneder-Geleff S, Soleiman A, Kowalski
H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler
E, Alitalo K and Kerjaschki D: Angiosarcomas express mixed
endothelial phenotypes of blood and lymphatic capillaries:
Podoplanin as a specific marker for lymphatic endothelium. Am J
Pathol. 154:385–394. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alitalo K, Tammela T and Petrova TV:
Lymphangiogenesis in development and human disease. Nature.
438:946–953. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karkkainen MJ, Haiko P, Sainio K, Partanen
J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala
H, et al: Vascular endothelial growth factor C is required for
sprouting of the first lymphatic vessels from embryonic veins. Nat
Immunol. 5:74–80. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Patel SP and Dana R: Corneal
lymphangiogenesis: Implications in immunity. Semin Ophthalmol.
24:135–138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
McCawley LJ and Matrisian LM: Matrix
metalloproteinases: Multifunctional contributors to tumor
progression. Mol Med Today. 6:149–156. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
d'Ortho MP, Will H, Atkinson S, Butler G,
Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L and Murphy G:
Membrane-type matrix metalloproteinases 1 and 2 exhibit
broad-spectrum proteolytic capacities comparable to many matrix
metalloproteinases. Eur J Biochem. 250:751–757. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koshikawa N, Giannelli G, Cirulli V,
Miyazaki K and Quaranta V: Role of cell surface metalloproteinase
MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol.
148:615–624. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sato H, Takino T and Miyamori H: Roles of
membrane-type matrix metalloproteinase-1 in tumor invasion and
metastasis. Cancer Sci. 96:212–217. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Genis L, Galvez BG, Gonzalo P and Arroyo
AG: MT1-MMP: Universal or particular player in angiogenesis? Cancer
Metastasis Rev. 25:77–86. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mimura T, Chang JH, Kim TI, Onguchi T,
Kojima T, Sakimoto T and Azar DT: MT1-MMP cleavage of the
antiangiogenic proteoglycan decorin: Role in corneal angiogenesis.
Cornea. 30:(Suppl 1). S45–S49. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ye HQ, Maeda M, Yu FS and Azar DT:
Differential expression of MT1-MMP (MMP-14) and collagenase III
(MMP-13) genes in normal and wounded rat corneas. Invest Ophthalmol
Vis Sci. 41:2894–2899. 2000.PubMed/NCBI
|
|
21
|
Hotary K, Allen E, Punturieri A, Yana I
and Weiss SJ: Regulation of cell invasion and morphogenesis in a
three-dimensional type I collagen matrix by membrane-type matrix
metalloproteinases 1, 2 and 3. J Cell Biol. 149:1309–1323. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cursiefen C, Chen L, Borges LP, Jackson D,
Cao J, Radziejewski C, D'Amore PA, Dana MR, Wiegand SJ and
Streilein JW: VEGF-A stimulates lymphangiogenesis and
hemangiogenesis in inflammatory neovascularization by macrophage
recruitment. J Clin Invest. 113:1040–1050. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stechschulte SU, Joussen AM, von Recum HA,
Poulaki V, Moromizato Y, Yuan J, D'Amato RJ, Kuo C and Adamis AP:
Rapid ocular angiogenic control via naked DNA delivery to cornea.
Invest Ophthalmol Vis Sci. 42:1975–1979. 2001.PubMed/NCBI
|
|
24
|
Cheng HC, Yeh SL, Tsao YP and Kuo PC:
Subconjunctival injection of recombinant AAV-angiostatin
ameliorates alkali burn induced corneal angiogenesis. Mol Vis.
13:2344–2352. 2007.PubMed/NCBI
|
|
25
|
Schefe JH, Lehmann KE, Buschmann IR, Unger
T and Funke-Kaiser H: Quantitative real-time RT-PCR data analysis:
current concepts and the novel “gene expression's CT difference”
formula. J Mol Med. 84:901–910. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Radonić A, Thulke S, Mackay IM, Landt O,
Siegert W and Nitsche A: Guideline to reference gene selection for
quantitative real-time PCR. Biochem Biophys Res Commun.
313:856–862. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang XL, Sun JF, Wang XY, Du LL and Liu P:
Blocking neuropilin-2 enhances corneal allograft survival by
selectively inhibiting lymphangiogenesis on vascularized beds. Mol
Vis. 16:2354–2361. 2010.PubMed/NCBI
|
|
28
|
Bock F, Onderka J, Hos D, Horn F, Martus P
and Cursiefen C: Improved semiautomatic method for morphometry of
angiogenesis and lymphangiogenesis in corneal flatmounts. Exp Eye
Res. 87:462–470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H, Hu X, Tse J, Tilahun F, Qiu M and
Chen L: Spontaneous lymphatic vessel formation and regression in
the murine cornea. Invest Ophthalmol Vis Sci. 52:334–338. 2010.
View Article : Google Scholar
|
|
30
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ingvarsen S, Porse A, Erpicum C, Maertens
L, Jürgensen HJ, Madsen DH, Melander MC, Gårdsvoll H, Høyer-Hansen
G, Noel A, et al: Targeting a single function of the
multifunctional matrix metalloproteinase MT1-MMP: Impact on
lymphangiogenesis. J Biol Chem. 288:10195–10204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Onguchi T, Han KY, Chang JH and Azar DT:
Membrane type-1 matrix metalloproteinase potentiates basic
fibroblast growth factor-induced corneal neovascularization. Am J
Pathol. 174:1564–1571. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matsubara M, Girard MT, Kublin CL, Cintron
C and Fini ME: Differential roles for two gelatinolytic enzymes of
the matrix metalloproteinase family in the remodelling cornea. Dev
Biol. 147:425–439. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shimoda M, Ishizaki M, Saiga T and
Yamanaka N: Expression of matrix metalloproteinases and tissue
inhibitor of metalloproteinase by myofibroblasts-morphological
study on corneal wound healing. Nippon Ganka Gakkai Zasshi.
101:371–379. 1997.(In Japanese). PubMed/NCBI
|
|
35
|
Fini ME, Girard MT and Matsubara M:
Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta
Ophthalmol Suppl. 26–33. 1992.PubMed/NCBI
|
|
36
|
Maruyama K, Ii M, Cursiefen C, Jackson DG,
Keino H, Tomita M, Van Rooijen N, Takenaka H, D'Amore PA,
Stein-Streilein J, et al: Inflammation-induced lymphangiogenesis in
the cornea arises from CD11b-positive macrophages. J Clin Invest.
115:2363–2372. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Watari K, Nakao S, Fotovati A, Basaki Y,
Hosoi F, Bereczky B, Higuchi R, Miyamoto T, Kuwano M and Ono M:
Role of macrophages in inflammatory lymphangiogenesis: Enhanced
production of vascular endothelial growth factor C and D through
NF-kappaB activation. Biochem and Biophys Res Commun. 377:826–831.
2008. View Article : Google Scholar
|
|
38
|
Ji RC: Macrophages are important mediators
of either tumor- or inflammation-induced lymphangiogenesis. Cell
Mol Life Sci. 69:897–914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Su JL, Yen CJ, Chen PS, Chuang SE, Hong
CC, Kuo IH, Chen HY, Hung MC and Kuo ML: The role of the
VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer. 96:541–545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bock F, Onderka J, Dietrich T, Bachmann B,
Pytowski B and Cursiefen C: Blockade of VEGFR3-signalling
specifically inhibits lymphangiogenesis in inflammatory corneal
neovascularisation. Graefes Arch Clin Exp Ophthalmol. 246:115–119.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kubo H, Cao R, Brakenhielm E, Mäkinen T,
Cao Y and Alitalo K: Blockade of vascular endothelial growth factor
receptor-3 signaling inhibits fibroblast growth factor-2-induced
lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA.
99:8868–8873. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cao R, Björndahl MA, Gallego MI, Chen S,
Religa P, Hansen AJ and Cao Y: Hepatocyte growth factor is a
lymphangiogenic factor with an indirect mechanism of action. Blood.
107:3531–3536. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shibuya M and Claesson-Welsh L: Signal
transduction by VEGF receptors in regulation of angiogenesis and
lymphangiogenesis. Exp Cell Res. 312:549–560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Goodin S: Development of monoclonal
antibodies for the treatment of colorectal cancer. Am J Health Syst
Pharm. 65:(Suppl 4). S3–S7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang ZS, Xu YF, Huang FF and Ding GF:
Associations of nm23H1, VEGF-C and VEGF-3 receptor in human
prostate cancer. Molecules. 19:6851–6862. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cao R, Eriksson A, Kubo H, Alitalo K, Cao
Y and Thyberg J: Comparative evaluation of FGF-2-, VEGF-A- and
VEGF-C-induced angiogenesis, lymphangiogenesis, vascular
fenestrations and permeability. Circ Res. 94:664–670. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Saaristo A, Veikkola T, Enholm B, Hytönen
M, Arola J, Pajusola K, Turunen P, Jeltsch M, Karkkainen MJ,
Kerjaschki D, et al: Adenoviral VEGF-C overexpression induces blood
vessel enlargement, tortuosity and leakiness but no sprouting
angiogenesis in the skin or mucous membranes. FASEB J.
16:1041–1049. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bauer SM, Bauer RJ, Liu ZJ, Chen H,
Goldstein L and Velazquez OC: Vascular endothelial growth factor-C
promotes vasculogenesis, angiogenesis and collagen constriction in
three-dimensional collagen gels. J Vasc Surg. 41:699–707. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Laakkonen P, Waltari M, Holopainen T,
Takahashi T, Pytowski B, Steiner P, Hicklin D, Persaud K, Tonra JR,
Witte L and Alitalo K: Vascular endothelial growth factor receptor
3 is involved in tumor angiogenesis and growth. Cancer Res.
67:593–599. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Valtola R, Salven P, Heikkilä P, Taipale
J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, de Waal R and
Alitalo K: VEGFR-3 and its ligand VEGF-C are associated with
angiogenesis in breast cancer. Am J Pathol. 154:1381–1390. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kumar B, Chile SA, Ray KB, Reddy GE,
Addepalli MK, Kumar AS, Ramana V and Rajagopal V: VEGF-C
differentially regulates VEGF-A expression in ocular and cancer
cells; promotes angiogenesis via RhoA mediated pathway.
Angiogenesis. 14:371–380. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shi VY, Bao L and Chan LS:
Inflammation-driven dermal lymphangiogenesis in atopic dermatitis
is associated with CD11b+ macrophage recruitment and
VEGF-C up-regulation in the IL-4-transgenic mouse model.
Microcirculation. 19:567–579. 2012. View Article : Google Scholar : PubMed/NCBI
|
